• GRUPPI DI RICERCA
  • Abrignani Lab
  • – Albanese Lab
  • Biffo Lab
  • – Manfrini Lab
  • Bodega Lab
  • – Marasca Lab
  • Cattaneo Lab
  • De Francesco Lab
  • Geginat Lab
  • Grassi Lab
  • Grifantini Lab
  • Lanzavecchia Lab
  • Lanzuolo Lab
  • Manganaro Lab
  • Montini Lab
  • Rizzello Lab
• PIATTAFORME
  • Bioinformatica
  • Citofluorimetria
  • Microscopia
  • Centro Organoidi
• PUBBLICAZIONI
  • Anno corrente
  • Archivio

• Decoration of gold nanoparticles with glycopeptides leads to a lower cellular uptake and liver retention.
  Soliman MG, Alarcon JF, Lüdtke TU, Violatto MB, Dobricic M, Cordiglieri C, Corbelli A, Fiordaliso F, Sitia G, O’Donnell JS, Spencer DIR, Moya S, Bigini P, Monopoli MP.
  Nanoscale Adv. 2025 Aug 12.
• Coupling mechanisms coordinating mRNA translation with stages of the mRNA lifecycle.
  Famà V, Coscujuela Tarrero L, Albanese R, Calviello L, Biffo S, Pelizzola M, Furlan M.
  RNA Biol. 2025 Dec;22(1):1-12.
• Lamin A/C regulates cerebellar granule cell maturation.
  Vilardo L, Cifola I, Nardella M, Pelucchi P, Ciotti MT, Bianchi A, Rinaldi A, Arisi I, Brandi R, d’Onofrio M, Galvanetto N, Gatti G, Catalano M, Lanzuolo C, Guglielmi L, D’Agnano I.
  Cell Biol Toxicol. 2025 Apr 5;41(1):66.
• The power of microRNA regulation-insights into immunity and metabolism.
  Oliveto S, Manfrini N, Biffo S.
  FEBS Lett. 2025 Jul;599(13):1821-1851.
• Nucleotide composition shapes gene expression in Wolbachia pipientis: a role for MidA methyltransferase?
  Papaleo S, Panelli S, Bitar I, Sterzi L, Nodari R, Comandatore F.
  mSystems. 2025 Aug 15:e0077925.
• Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy.
  Bonazzi E, De Barba C, Lorenzon G, Maniero D, Bertin L, Barberio B, Facciotti F, Caprioli F, Scaldaferri F, Zingone F, Savarino EV.
  Expert Rev Gastroenterol Hepatol. 2025 Apr-May;19(5):563-576.
• Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers.
  Tarantino S, Bianco A, De Matteis V, Scarpa E, Rinaldi R.
  Ibrain. 2025 May 10;11(2):119-145.
• Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers.
  Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fiore S, Di Martino A, Abrignani S, Bandera A, Clerici P, De Paschale M, Fallucca A, Fortunato F, Gori A, Grifantini R, Lazzarotto T, Lodi V, Orsi A, Prato R, Restivo V, Ricucci V, Palamara AT, Stefanelli P; COVAC-2 Study Group.
  Vaccine. 2025 Jul 30:62:127524.
• Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials.
  Piscaglia M, Scaglione G, Genovese C, Borgonovo F, Brivio F, Rampichini F, Grifantini R, Bandera A, Gori A, Colaneri M, Palomba E.
  Infect Dis Ther. 2025 Aug;14(8):1619-1647.
• GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growth.
  Pesce E, Sodini A, Palmieri E, Valensin S, Tinti C, Rossi M, De Rosa A, Fragai M, Papi F, Cordiglieri C, Berti F, Grifantini R*, Micoli F*, Nativi C*.
  NPJ Vaccines. 2025 Apr 15;10(1):71.
• A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.
  Lucini Paioni A, Donnici L, Nodari R, Longo Minnolo M, Ferraro A, Alberico A , Brindisi M, MejíasPérez E, Keppler OT , Summa V , Guidotti LG , Albanese M & De Francesco R
  Virology 2025, doi:10.1016/j.virol.2025.110659
• FAM46C Expression Sensitizes Multiple Myeloma Cells to PF-543-Induced Cytotoxicity.
  Miluzio A, De Grossi F, Mancino M, Biffo S, Manfrini N.
  Biomolecules. 2025 Apr 26;15(5):623.
• Biomimetic Recognition of SARS-CoV-2 Receptor-Binding Domain N-Glycans by an Antiviral Synthetic Receptor.
  Santambrogio C, Toccafondi M, Donnici L, Pesce E, De Francesco R, Grifantini R, Ponzini E, Milanesi F, Fragai M, Nativi C, Roelens S, Grandori R, Francesconi O.
  Chembiochem. 2025 Feb 21:e202500106.
• Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy.
  Cazzaniga G, Mori M, Griego A, Scarpa E, Moschetti G, Muzzioli S, Stelitano G, Chiarelli LR, Cocorullo M, Casali E, Porta A, Zanoni G, Tresoldi A, Pini E, Batalha ÍL, Battaglia G, Tuccinardi T, Rizzello L, Villa S, Meneghetti F.
  J Med Chem. 2025 Mar 13;68(5):5312-5332.
• Biomimetic Recognition of SARS-CoV-2 Receptor-Binding Domain N-Glycans by an Antiviral Synthetic Receptor.
  Santambrogio C, Toccafondi M, Donnici L, Pesce E, De Francesco R, Grifantini R, Ponzini E, Milanesi F, Fragai M, Nativi C, Roelens S, Grandori R, Francesconi O.
  Chembiochem. 2025 Feb 21:e202500106.
• V-ATPase in glioma stem cells: a novel metabolic vulnerability.
  Storaci AM, Bertolini I, Martelli C, De Turris G, Mansour N, Crosti M, De Filippo MR, Ottobrini L, Valenti L, Polledri E, Fustinoni S, Caroli M, Fanizzi C, Bosari S, Ferrero S, Zadra G, Vaira V.
  J Exp Clin Cancer Res. 2025 Jan 17;44(1):17.
• Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington’s disease.
  Maestri S, Scalzo D, Damaggio G, Zobel M, Besusso D, Cattaneo E.
  Nucleic Acids Res. 2025 Jan 7;53(1):gkae1155.
• When repetita no-longer iuvant: somatic instability of the CAG triplet in Huntington’s disease.
  Cattaneo E, Scalzo D, Zobel M, Iennaco R, Maffezzini C, Besusso D, Maestri S.
  Nucleic Acids Res. 2025 Jan 7;53(1):gkae1204.
• Macrophages producing chondroitin sulfate proteoglycan-4 induce neuro-cardiac junction impairment in Duchenne muscular dystrophy.
  Milan M, Maiullari F, Chirivì M, Ceraolo MG, Zigiotto R, Soluri A, Maiullari S, Landoni E, Silvestre DD, Brambilla F, Mauri P, De Paolis V, Fratini N, Crosti MC, Cordiglieri C, Parisi C, Calogero A, Seliktar D, Torrente Y, Lanzuolo C, Dotti G, Toccafondi M, Bombaci M, De Falco E, Bearzi C, Rizzi R.
  J Pathol. 2025 Jan;265(1):1-13.
• eIF3d specialized translation requires a RACK1-driven eIF3d binding to 43S PIC in proliferating SH-SY5Y neuroblastoma cells.
  Silvestri F, Montuoro R, Catalani E, Tilesi F, Willems D, Romano N, Ricciardi S, Cervia D, Ceci M.
  Cell Signal. 2025 Jan;125:111494.
• Modulation of Autophagy by Oncosuppressor FAM46C and Its Implications for Cancer Therapy: An Intriguing Perspective.
  Manfrini N.
  Biomolecules. 2025 Jan 30;15(2):196.
• Dual Activation-Induced Marker Combinations Efficiently Identify and Discern Antigen-Specific and Bystander-Activated Human CD4+ T Cells.
  Ceraolo MG, Leccese M, Cassotta A, Triolo S, Bombaci M, Coluccio E, Prati D, Ungaro R, Abrignani S, Bandera A, Sallusto F, Lanzavecchia A, Notarbartolo S.
  Eur J Immunol. 2025 Feb;55(2):e202451404.

INGM RESEARCH IS SUPPORTED BY